WASHINGTON DC – Food and Drug Administration officials said they are taking steps to announce a plan for how to regulate cannabis-derived products like CBD and delta-8 THC in the coming months. This comes as the agency is also leading a review into marijuana’s scheduling status.
Congressional Cannabis Caucus co-chairs Reps. Earl Blumenauer (D-OR), Dave Joyce (R-OH), Barbara Lee (D-CA) and Brian Mast (R-FL) released a new memo reviewing marijuana reform accomplishments achieved this year and looking ahead at possibilities for 2023.
Kansas House Democrats are renewing their call to legalize medical marijuana in 2023 after police in Hays, Kansas raided a terminally ill cancer patient’s hospital room over his use of medical cannabis extracts.
The Congressional Research Service published a new report on issues faced by the hemp industry and how they can be addressed in the next Farm Bill.
A new NORML analysis indicates that researchers published a record number of scientific studies about cannabis in 2022.
To read more, click on Marijuana Moment
